Bill

Bill > HR4030


US HR4030

US HR4030
Treatment Continuity Act of 2025


summary

Introduced
06/17/2025
In Committee
06/17/2025
Crossed Over
Passed
Dead

Introduced Session

119th Congress

Bill Summary

A BILL To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes.

AI Summary

This bill amends the Public Health Service Act to expand support for treating substance use disorders and serious mental illness by authorizing the Secretary of Health and Human Services to provide grants for several key initiatives. Specifically, the bill focuses on improving access to long-acting injectable medications approved by the FDA for treating substance use disorders and serious mental illness, along with supporting lab testing, counseling services, and training for healthcare providers on using these medications. The legislation requires the Secretary to submit an annual report to Congress detailing the program's outcomes and progress, including assessments from clinical professionals about treatment requirements. The changes will apply to grants issued under this section of the Public Health Service Act after the bill's enactment. By broadening the scope of existing programs, the bill aims to enhance treatment options and continuity of care for individuals struggling with substance use disorders and serious mental health conditions, potentially improving overall patient outcomes and healthcare support.

Committee Categories

Business and Industry

Sponsors (4)

Last Action

Referred to the House Committee on Energy and Commerce. (on 06/17/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...